Treatment Agreements Do Not Change Clinicians' Permissive Attitudes of Cannabis Use Among Patients on Long-Term Opioid Therapy.
作者信息
Fried Martin, Joshi Shivam, Thomas Nicole, Richards Nathan, Svirsky Larisa, Zettler Patricia J, Howard Dana
机构信息
Division of General Internal Medicine, Ohio State University College of Medicine, Columbus, OH, USA.
Center for Biostatistics, Ohio State University Wexner Medical Center, Columbus, OH, USA.
出版信息
J Gen Intern Med. 2025 May;40(7):1687-1689. doi: 10.1007/s11606-024-09206-7. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Treatment Agreements Do Not Change Clinicians' Permissive Attitudes of Cannabis Use Among Patients on Long-Term Opioid Therapy.
J Gen Intern Med. 2025 May;40(7):1687-1689. doi: 10.1007/s11606-024-09206-7. Epub 2024 Nov 25.
2
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment.
Drug Alcohol Rev. 2025 Jul;44(5):1339-1350. doi: 10.1111/dar.14074. Epub 2025 May 5.
3
The Legal Landscape for Opioid Treatment Agreements.
Milbank Q. 2024 Sep;102(3):632-668. doi: 10.1111/1468-0009.12699. Epub 2024 May 10.
4
A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.
Subst Abus. 2023 Oct;44(4):337-347. doi: 10.1177/08897077231202836. Epub 2023 Oct 30.
5
Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial.
Drug Alcohol Depend. 2025 Mar 1;268:112550. doi: 10.1016/j.drugalcdep.2025.112550. Epub 2025 Jan 18.
6
Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence.
Addiction. 2022 Feb;117(2):284-298. doi: 10.1111/add.15581. Epub 2021 Jul 15.
7
Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study.
J Gen Intern Med. 2024 Sep;39(12):2179-2186. doi: 10.1007/s11606-023-08586-6. Epub 2024 Jan 16.
9
Cannabidiol in the context of substance use disorder treatment: A systematic review.
Addict Behav. 2022 Sep;132:107360. doi: 10.1016/j.addbeh.2022.107360. Epub 2022 May 7.
10
Interventions to reduce harm from continued tobacco use.
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
本文引用的文献
1
Redesigning Opioid Pain Agreements to Promote Patient-Centered Care.
JAMA Intern Med. 2023 Mar 1;183(3):179-180. doi: 10.1001/jamainternmed.2022.6520.
2
Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.
BMJ Open. 2022 Aug 4;12(8):e054282. doi: 10.1136/bmjopen-2021-054282.
3
Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.
BMC Fam Pract. 2021 Oct 21;22(1):212. doi: 10.1186/s12875-021-01559-w.
4
Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy.
Cleve Clin J Med. 2016 Nov;83(11):827-835. doi: 10.3949/ccjm.83a.15172.
5
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates.
AMA J Ethics. 2015 Jun 1;17(6):558-61. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.
Zotero 插件